National Institute of Allergy and Infectious Diseases; Notice of Meeting, 17672 [E9-8662]
Download as PDF
<![CDATA[
17672
Federal Register / Vol. 74, No. 72 / Thursday, April 16, 2009 / Notices
received after this date, but
consideration of late submissions is not
guaranteed. Individuals may apply for,
or nominate another individual for,
membership on the Council. Each
nomination or application must include:
a. The name and title of the applicant
or nominee and a description of the
interest the applicant or nominee will
represent;
b. The applicant’s or nominee’s mail
address, e-mail address, telephone
number, and facsimile number (where
available);
c. Reasons why the applicant or
nominee should be appointed to the
Council; and the basis for determining
the applicant or nominee has achieved
peer recognition as a technical expert.
Federal Communications Commission.
Jon M. Peha,
Chief Technologist.
[FR Doc. E9–8775 Filed 4–15–09; 8:45 am]
BILLING CODE 6712–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Meeting
mstockstill on PROD1PC66 with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the AIDS
Research Advisory Committee, NIAID.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: AIDS Research
Advisory Committee, NIAID; AIDS Vaccine
Research Subcommittee.
Date: May 19–20, 2009.
Time: May 19, 2009, 8:30 a.m. to 5 p.m.
Agenda: To review recent research
advances in the B-cell immunology field as
they relate to AIDS vaccine development.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Time: May 20, 2009, 8:30 a.m. to
Ajournment.
Agenda: To review recent research
advances in the B-cell immunology field as
they relate to AIDS vaccine development.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: James A. Bradac, PhD,
Program Official, Preclinical Research and
Development Branch, Division of AIDS,
Room 5116, National Institutes of Health/
NIAID, 6700B Rockledge Drive, Bethesda,
MD 20892–7628. 301–435–3754.
jbradac@mail.nih.gov.
VerDate Nov<24>2008
16:47 Apr 15, 2009
Jkt 217001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: April 9, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–8662 Filed 4–15–09; 8:45 am]
Privacy Act of 1974; Notice of Modified
System of Records
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be open to the public,
with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ‘‘Comparative
Evaluation of Assisted Reproductive
Technologies and Birth Outcomes’’.
Date: May 6, 2009.
Time: 2 p.m. to 3 p.m.
Agenda: To provide concept review of
proposed concept review.
Place: National Institutes of Health, 6100
Executive Boulevard Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
PhD, Scientific Review Administrator,
Division of Scientific Review, National
Institute of Child Health and Human
Development, 6100 Executive Boulevard,
Room 5B01, Bethesda, MD 20892–9304, (301)
435–6680, skandasamail@.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: April 7, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–8670 Filed 4–15–09; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Centers for Medicare & Medicaid
Services
AGENCY: Department of Health and
Human Services (HHS), Centers for
Medicare & Medicaid Services (CMS).
ACTION: Notice of a modified system of
records.
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
CMS is proposing to make minor
amendments to an existing system of
records (SOR) titled, ‘‘Performance
Measurement and Reporting System
(PMRS),’’ System No. 09–70–0584,
published at 72 Federal Register 52133
(September 12, 2007), as amended by 73
Federal Register 80412 (December 31,
2008). PMRS serves as a master system
of records to assist in projects that
provide transparency in health care on
a broad-scale enabling consumers to
compare the quality and price of health
care services so that they can make
informed choices among individual
physicians, practitioners, and other
providers of services. We are making
minor amendments to PMRS to include
an additional legal authority: Section
109 of the Tax Relief and Health Care
Act of 2006 (TRHCA) (Pub. L. 109–432).
Section 109 of the TRHCA amended
Section 1833(t) of the Social Security
Act (42 U.S.C. 1395l(t)). This section
mandates the establishment of a
program for quality data reporting for
hospital outpatient services and allow
for the establishment of a program to
require quality data reporting for
ambulatory surgical center services.
Accordingly, CMS is adding section 109
of TRCHA (42 U.S.C. 1395l(t)) and
section 1833(t) of the Act to the PMRS’
legal authority section.
The primary purpose of this system is
explained in 72 FR 52133 (2007) and 73
FR 80412 (2008). We have provided
background information about this
modified system in the SUPPLEMENTARY
INFORMATION section below.
DATES: Effective Dates: The minor
amendments contained in this notice
are effective upon publication in the
Federal Register.
FOR FURTHER INFORMATION CONTACT:
Aucha Prachanronarong, Health
Insurance Specialist, Division of
Ambulatory Care and Measure
Management, Quality Measurement and
Health Assessment Group, Office of
Clinical Standards and Quality, CMS,
Room C1–23–14, 7500 Security
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 74, Number 72 (Thursday, April 16, 2009)]
[Notices]
[Page 17672]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-8662]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
AIDS Research Advisory Committee, NIAID.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: AIDS Research Advisory Committee, NIAID; AIDS
Vaccine Research Subcommittee.
Date: May 19-20, 2009.
Time: May 19, 2009, 8:30 a.m. to 5 p.m.
Agenda: To review recent research advances in the B-cell
immunology field as they relate to AIDS vaccine development.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Time: May 20, 2009, 8:30 a.m. to Ajournment.
Agenda: To review recent research advances in the B-cell
immunology field as they relate to AIDS vaccine development.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD
20814.
Contact Person: James A. Bradac, PhD, Program Official,
Preclinical Research and Development Branch, Division of AIDS, Room
5116, National Institutes of Health/NIAID, 6700B Rockledge Drive,
Bethesda, MD 20892-7628. 301-435-3754. jbradac@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 9, 2009.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-8662 Filed 4-15-09; 8:45 am]
BILLING CODE 4140-01-P
